Triumvira Appoints Teresa McRoberts as Chief Financial Officer and Announces Senior Level Promotions

Ontario Industry Updates
Written By Viktoriya Shabat
Triumvira.jpg

AUSTIN, Texas & HAMILTON, Ontario - Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today announced the appointment of Teresa McRoberts as Chief Financial Officer. The Company also announced the promotion of Andreas Bader, Ph.D. to Chief Scientific Officer and Jon Irvin to Senior Vice President of Finance.

Viktoriya Shabat
Previous

CTI Life Sciences Fund Raises $100 Million in First Close of Third Venture Fund
Next

Register by May 25 to Learn About Creating Your Best Pitch with Brian Bordley, Investor, SkyDeck Fund